Hero has been granted a patent for a nutritional composition with specific energy, protein, fat, fatty acid, sialic acid, cholesterol, and sphingomyelin content. The composition, which can be a ready-to-use product or reconstituted from a dry powder, aims to support cognitive development in infants and achieve similar scores to breast-fed infants. GlobalData’s report on Hero gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Hero, microbiota restoration therapy was a key innovation area identified from patents. Hero's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
Patent granted for a nutritional composition for infants
A recently granted patent (Publication Number: US11647777B2) describes a nutritional composition that can be used as a ready-to-use product or reconstituted with water from a dry powder. The composition is designed to provide a total energy content of 60 kcal/100 ml to 67 kcal/100 ml. It includes a protein content of 1.1 to 1.2 g/100 ml, with the energy content from protein accounting for 7.2-8.4% of the total energy content. The composition also contains a medium chain fatty acid content comprising 8 to 10 carbons, representing 0.5 to 2% of the total amount of fatty acids.
Additionally, the composition includes milk-derived sialic acid, with a content of 10-25 mg/100 ml, of which 1.5-5% is lipid bound sialic acid as gangliosides. The composition also contains milk-derived cholesterol (5-10 mg/100 ml), whey protein concentrate solids (present in an amount of 5.35 g/L to 6.27 g/L), milk-derived sphingomyelin (9-15 mg/100 ml), and a non-protein nitrogen (NPN) value of 0.015-0.020 g/100 ml. The protein used in the composition is non-human protein, specifically cow milk protein.
The patent claims that when this nutritional composition is orally delivered to an infant as an infant formula, the infant achieves a cognitive development score that is within 3% of the score of breast-fed infants, as measured at 12 months by the Bayley Scales of Infant and Toddler Development-III. The composition aims to provide a growth parameter for the infant that does not differ from that of a similar breastfed infant, with the growth parameter being selected from weight, length, head circumference, body mass index, and combinations thereof.
Overall, this patent describes a nutritional composition that aims to provide a balanced and nutritious formula for infants, with specific attention to cognitive development and growth parameters. The composition includes various milk-derived components, proteins, fatty acids, and other nutrients to support the healthy development of infants.
To know more about GlobalData’s detailed insights on Hero, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
